rna
interfer
rnai
certainli
first
mechan
therapeut
potenti
base
nucleic
acid
idea
use
nucleic
acidbas
inhibitor
gene
express
stem
research
perform
antisens
dna
oligonucleotid
could
chemic
synthes
first
time
scientist
high
hope
antisens
thu
far
singl
drug
call
vitraven
clear
food
drug
administr
fda
current
use
treat
cytomegalovirusinduc
eye
infect
acquir
immunodefici
syndrom
aid
patient
exploit
dnabas
therapeut
agent
remain
limit
deliveri
problem
unpredict
effect
similarli
ribozym
held
promis
one
ribozymebas
drug
come
market
rnai
chang
momentum
acuiti
pharmaceut
philadelphia
file
investig
new
drug
applic
fda
august
begin
test
small
interf
rna
sirna
treatment
wet
form
agerel
macular
degener
amd
still
could
year
first
rnai
drug
approv
consum
use
field
move
unpreced
speed
rnai
pathway
commonli
consid
cellular
defenc
mechan
virus
use
therapeut
tool
pathogen
virus
summar
current
statu
rnaimedi
inhibit
viru
replic
discuss
possibl
develop
rnaibas
antivir
therapeut
rnai
cellular
regulatori
pathway
trigger
respons
doublestrand
rna
dsrna
hannon
sinc
first
descript
caenorhabd
elegan
rnai
found
exist
mani
eukaryot
organ
involv
extraordinari
number
genesilenc
phenomena
fire
et
al
hannon
rnai
machineri
consist
conserv
core
factor
role
recogn
process
effect
respons
dsrna
microrna
mirna
grow
famili
small
nonproteincod
regulatori
transcript
found
mani
eukaryot
organ
mirna
process
via
rnai
machineri
shown
regul
express
homolog
targetgen
transcript
mirna
first
describ
c
elegan
transcript
target
untransl
region
utr
development
transcript
factor
suppress
translat
grishok
et
al
reinhart
et
al
vella
et
al
current
estim
number
mirna
repres
predict
number
gene
mammalian
genom
similar
proport
repres
larg
gene
famili
transcript
factor
comput
method
use
identifi
target
expect
result
provid
clue
mechan
action
particular
mirna
lai
mirna
target
pair
describ
becam
appar
regul
develop
might
common
theme
mirna
biolog
mirna
target
found
affect
divers
process
includ
flower
time
leaf
pattern
arabidopsi
neuron
asymmetri
c
elegan
development
regul
cell
prolifer
drosophila
aukerman
sakai
brenneck
et
al
kidner
martienssen
palatnik
et
al
littl
known
role
mirna
mammal
field
move
fast
miska
et
al
mirna
gene
often
locat
cluster
appear
transcrib
polycistron
transcript
lee
et
al
perhap
surprisingli
neither
mirna
promot
rna
polymeras
respons
mirna
transcript
character
detail
thu
far
howev
recent
evid
indic
human
mirna
process
cap
polyadenyl
transcript
also
function
messeng
rna
cai
et
al
also
clear
mirna
gene
often
strict
developmentaland
tissuespecif
control
dosti
et
al
houbaviy
et
al
krichevski
et
al
lagosquintana
et
al
moss
tang
mani
primari
mirna
transcript
predict
comput
algorithm
adopt
elabor
stemloop
structur
lau
et
al
lee
ambro
mourelato
et
al
cleavag
stemloop
rnase
iii
enzym
drosha
liber
approxim
nt
precursor
mirna
premirna
rna
characterist
twont
overhang
end
structur
left
stagger
cut
rnase
iii
enzym
recent
studi
shown
mediat
nuclear
export
premirna
ranguanosin
triphosph
gtp
depend
manner
bohnsack
et
al
lund
et
al
yi
et
al
interestingli
nuclear
export
anoth
cargo
rna
adenoviru
noncod
rna
also
requir
twoto
threent
overhang
gwizdek
et
al
suggest
structur
determin
recognit
may
implicit
drosha
process
entri
cytoplasm
bring
premirna
contact
dicer
predominantli
cytoplasm
enzym
billi
et
al
findley
et
al
provost
et
al
dicer
cleav
premirna
matur
mirna
also
cleav
dsrna
sirna
grishok
et
al
hutvagn
et
al
ket
et
al
knight
bass
dicer
modular
enzym
compos
two
rnaseiii
domain
dexhdeah
box
rna
helicas
domain
paz
domain
well
domain
unknown
function
doublestrand
rnabind
motif
dicer
cleavag
follow
releas
matur
mirna
sirna
incorpor
risc
rnainduc
silenc
complex
effector
complex
whose
divers
function
includ
mrna
cleavag
translat
suppress
transcript
silenc
heterochromatin
format
c
elegan
doublestrand
rnabind
protein
drosophila
homologu
facilit
transfer
sirna
risc
liu
et
al
tabara
et
al
also
like
number
addit
compon
aid
risc
assembl
tomari
et
al
particularli
unwind
sirna
mirna
action
determin
rna
strand
chosen
silenc
schwarz
et
al
strand
mirna
sirna
duplex
preferenti
incorpor
risc
also
determin
thermodynam
properti
nucleic
acid
duplex
martinez
et
al
schwarz
et
al
risc
ribonucleoprotein
complex
contain
member
pazpiwi
domain
argonaut
famili
protein
sirna
mirna
mirnasirna
complementari
mrna
argonaut
protein
recogn
overhang
singlestrand
ss
rna
crucial
compon
risc
load
ssrna
guid
search
mrna
complementari
sequenc
defin
actual
site
cleavag
base
overhang
first
crystal
structur
archaeal
argonaut
protein
reveal
rnasehlik
fold
catalyt
aspaspglu
dde
motif
rna
cleavag
suggest
protein
actual
rna
slicer
parker
et
al
song
et
al
mammalian
cell
four
argonaut
homologu
recent
evid
suggest
rnacleav
activ
rand
et
al
may
divis
labour
argonaut
instanc
drosophila
melanogast
recent
shown
unwind
sirna
prerequisit
sirnamedi
cleavag
interact
directli
dicer
lead
stabil
matur
mirna
okamura
et
al
endonucleolyt
cleavag
risc
gener
two
rna
fragment
hydroxyl
phosphat
schwarz
et
al
mrna
fragment
must
elimin
may
encod
unwant
polypeptid
fragment
translat
fate
mrna
cleavag
product
remain
unclear
time
recent
evid
implic
exonucleas
cytoplasm
enzym
arabidopsi
remov
fragment
gazzani
et
al
souret
et
al
risc
contain
number
accessori
factor
activ
necessari
effector
function
precis
biochem
mechan
wherebi
risc
carri
function
unknown
two
wellcharacter
risc
activ
mrna
cleavag
translat
suppress
risc
multipleturnov
enzym
complex
incorpor
sirna
mirna
direct
multipl
round
target
cleavag
hutvagn
zamor
whether
risc
also
act
catalyt
manner
mediat
translat
suppress
clear
also
known
whether
mirnamrna
duplex
requir
specif
featur
eg
mismatch
recogn
factor
mediat
translat
repress
recent
evid
indic
primari
function
mirna
guid
associ
protein
mrna
tether
ago
protein
utr
mrna
mean
also
result
translat
repress
pillai
et
al
although
mirna
molecul
thought
act
posttranscript
level
interf
mrna
accumul
evid
noncod
rna
molecul
involv
transcript
silenc
heterochromatin
format
well
rnai
known
work
transcript
plant
methyl
gene
promot
sequenc
complement
rna
de
novo
cytosin
methyl
genom
dna
shown
occur
plant
infect
rna
viroid
whose
sequenc
homolog
methyl
genom
sequenc
wassenegg
et
al
process
refer
rnadirect
dna
methyl
rddm
subsequ
dsrna
target
promot
region
shown
induc
rddm
trigger
transcript
silenc
silenc
accompani
sirna
product
point
rnailik
mechan
gene
silenc
transcript
level
mett
et
al
recent
evid
dna
methyl
gene
silenc
also
induc
sirna
human
cell
kawasaki
taira
morri
et
al
cell
typic
pass
dnaregul
modif
daughter
cell
possibl
permit
last
inhibitori
effect
rnai
link
heterochromatin
format
gene
silenc
chromosom
segreg
fission
yeast
transcript
deriv
outer
centromer
repeat
yeast
chromosom
chop
rnai
machineri
thu
form
sirna
requir
format
heterochromatin
outer
repeat
chromosom
analysi
mammalian
cell
condit
knockout
dicer
suggest
rnai
also
play
role
heterochromatin
format
centromer
vertebr
fukagawa
et
al
second
dna
pathway
could
provid
altern
mean
inhibit
certain
virus
rnai
particular
virus
util
dna
transcript
part
replic
strategi
includ
dna
virus
retrovirus
compar
rna
phase
exist
dna
phase
rnai
machineri
could
provid
longerlast
effect
thu
open
new
therapeut
strategi
hand
broader
mechan
action
also
increas
likelihood
unintend
consequ
offtarget
silenc
result
detail
biochem
studi
suggest
need
revis
current
design
rule
construct
sirna
schwarz
et
al
one
could
select
rna
target
correspond
sirna
molecul
optim
thermodynam
signatur
natur
occur
mirna
show
strong
bia
accumul
one
strand
function
risc
complex
bartel
cours
identifi
activ
specif
sirna
notic
sequenc
composit
sirna
duplex
influenc
ratio
sens
antisens
complementari
target
gene
sirna
enter
risc
complex
schwarz
et
al
particularli
import
low
basepair
stabil
end
antisens
strand
rel
end
increas
chanc
antisens
strand
enter
risc
complex
addit
advantag
bias
uptak
risc
less
offtarget
effect
risc
complex
load
sens
strand
drosophila
orient
protein
heterodim
determin
sirna
strand
associ
core
risc
protein
argonaut
tomari
et
al
bind
sirna
end
greatest
doublestrand
charact
therebi
orient
heterodim
sirna
duplex
strong
bind
requir
phosphat
rnai
strand
subsequ
exclud
risc
explain
rel
low
basepair
end
antisens
strand
benefici
case
select
sirna
still
suboptim
one
could
improv
thermodynam
signatur
alter
structur
sirna
duplex
done
introduct
weak
gu
basepair
intern
loop
bulg
distinct
posit
within
duplex
obvious
without
chang
antisens
strand
mediat
subsequ
mrnacleavag
cell
may
even
feasibl
convert
adenosin
inosin
within
dsrna
rna
edit
enzym
tonkin
bass
case
synthet
sirna
one
could
introduc
chemic
modif
specif
posit
within
sens
strand
sirna
molecul
reach
optim
thermodynam
signatur
chemic
modif
one
strand
may
also
use
either
block
risc
incorpor
sens
strand
trigger
incorpor
antisens
strand
optim
also
reduc
likelihood
sensestranddirect
offtarget
effect
aspect
may
also
influenc
choic
optim
antivir
includ
effect
rna
secondari
structur
target
presenc
target
rnaassoci
protein
target
viral
pathogen
also
particularli
import
consid
degre
target
sequenc
conserv
among
viru
isol
instanc
select
eight
sirna
wellconserv
highli
access
domain
human
immunodefici
viru
hiv
rna
genom
major
molecul
ineffect
possibl
obey
new
rule
optim
sirnadesign
da
et
al
addit
chemic
enzymat
synthes
sirna
cell
conveni
way
induc
rnai
laboratori
set
stabl
intracellular
express
may
requir
sever
therapeut
applic
first
vector
express
function
sirna
mostli
short
hairpin
sh
rna
describ
brummelkamp
et
al
paddison
et
al
sever
improv
report
much
optim
still
expect
rna
polymeras
iii
pol
iii
promot
wide
use
express
shrna
silenc
varieti
target
gene
brummelkamp
et
al
sever
modif
system
recent
publish
report
enhanc
cytomegaloviru
immediateearli
promot
pol
ii
unit
enhanc
synthesi
sirna
pol
iii
unit
xia
et
al
two
differ
human
pol
iii
promot
wide
use
natur
encod
either
small
nuclear
sn
rna
unit
part
rnase
p
molecul
unit
effici
sirna
express
recent
report
modifi
transfer
rna
met
promot
mtd
unit
boden
et
al
anoth
major
improv
design
doxycyclineregul
promot
allow
induc
knockdown
gene
express
sirna
van
de
weter
et
al
similarli
doxycyclineinduc
sirna
express
cassett
insert
lentiviru
vector
wiznerowicz
trono
altern
ecdyson
system
transplant
onto
promot
induc
shrna
express
gupta
et
al
creloxp
recombin
system
also
use
switch
shrna
express
would
allow
regul
spatial
tempor
cellor
tissuespecif
manner
kasim
et
al
induc
system
particularli
use
studi
protein
impact
cell
growth
cell
differenti
eg
oncogen
tumoursuppressor
gene
presenc
invert
repeat
encod
hairpin
rna
may
affect
stabil
vector
converg
transcript
unit
two
oppos
promot
therefor
design
tran
et
al
strategi
express
multival
shrna
construct
also
describ
seem
import
avoid
danger
viral
escap
berkhout
much
remain
learnt
shrna
design
rule
featur
promot
effici
shrna
express
modif
intracellular
transport
process
etc
instanc
detail
mutat
analysi
elegantli
demonstr
possibl
introduc
multipl
gu
basepair
mutat
sens
strand
virus
induc
target
rna
silenc
plant
vanc
vaucheret
antivir
capac
rna
silenc
use
tool
gener
viru
resist
plant
lindbo
dougherti
smith
et
al
waterhous
et
al
rnai
technolog
current
use
inhibit
viral
replic
anim
cell
promis
result
obtain
rnai
sever
anim
virus
vitro
vivo
set
first
demonstr
rnaimedi
inhibit
human
pathogen
viru
report
barik
bitko
barik
author
report
tenfold
inhibit
human
respiratori
syncyti
viru
hrsv
replic
vitro
use
nanomolar
concentr
synthet
sirna
target
viral
polymeras
subunit
p
fusion
protein
f
current
mani
studi
describ
rnaimedi
inhibit
larg
varieti
virus
rnaimedi
inhibit
receiv
much
attent
see
tabl
addit
differ
rna
virus
differ
dna
virus
effici
target
rnai
tabl
initi
standard
method
induc
rnai
toward
virus
mammalian
cell
transfect
synthet
sirna
correspond
viral
sequenc
shortli
viral
challeng
current
transient
transfect
plasmid
express
antivir
shrna
also
commonli
use
strategi
result
potent
albeit
temporari
inhibit
viru
replic
order
obtain
longterm
viru
resist
research
turn
combin
rnaigen
therapi
approach
approach
lenti
retroor
adenoassoci
viru
aav
vector
use
stabli
transduc
cell
construct
express
shrna
result
viral
resist
provid
complet
overview
antivir
studi
tabl
discuss
possibl
develop
rnaibas
antivir
therapi
focu
rna
dna
virus
sever
studi
report
sirna
suppress
capodici
et
al
coburn
cullen
hu
et
al
jacqu
et
al
lee
et
al
martinez
et
al
novina
et
al
park
et
al
qin
et
al
surabhi
gaynor
evid
suggest
genom
rna
present
within
infect
virion
particl
target
destruct
appear
new
viral
transcript
synthes
integr
proviru
effici
target
studi
use
chemic
synthes
sirna
transfect
cell
either
shortli
challeng
despit
transient
natur
transfect
experi
singl
sirna
applic
abl
achiev
rel
longlast
suppress
song
et
al
studi
use
transient
transfect
sirnaexpress
vector
howev
develop
effici
vector
deliveri
system
capabl
mediat
stabl
sirna
express
matur
lymphocyt
progenitor
stem
cell
minim
requir
rnai
use
therapeut
modal
lentivir
vector
pol
iii
express
cassett
effici
mean
deliv
antihiv
sirna
haematopoiet
precursor
cell
recent
report
transduc
human
cell
allow
differenti
vivo
scidhu
thymopoiesi
mous
model
matur
lymphocyt
deriv
model
resist
infect
ex
vivo
two
studi
address
potenc
durabl
antihiv
rnai
approach
boden
et
al
express
shrna
tat
gene
aav
vector
boden
et
al
potent
inhibit
score
escap
viru
variant
appear
prolong
cultur
similar
result
describ
da
et
al
use
lentivir
vector
unit
express
sirna
sequenc
nef
gene
da
et
al
latter
studi
describ
seven
independ
escap
variant
combin
result
convincingli
demonstr
inhibit
potent
sequencespecif
also
abl
escap
inhibitori
action
singl
sirna
boden
et
al
describ
singl
revert
point
mutat
target
sequenc
da
et
al
describ
larg
varieti
escap
rout
point
mutat
doubl
point
mutat
partial
complet
delet
target
sequenc
deletionbas
resist
mechan
seem
imposs
case
essenti
gene
critic
sequenc
motif
target
thu
one
preferenti
target
essenti
sequenc
well
conserv
among
isol
interest
target
rel
littl
mutat
freedom
multipl
overlap
read
frame
within
genom
includ
tripl
overlap
tagrevenv
ideal
one
target
one
essenti
wellconserv
viral
sequenc
combin
sirnatherapi
mimic
success
strategi
combat
multipl
antivir
drug
avoid
evolut
escap
variant
recent
discov
altern
resist
mechan
trigger
mutat
target
sequenc
instead
mutat
flank
sequenc
select
subsequ
shown
induc
conform
chang
within
target
sequenc
protect
risc
attack
westerhout
et
al
find
indic
straightforward
predict
viral
escap
rout
nevertheless
one
could
make
first
estim
chanc
viral
escap
therapeut
set
sirna
chemic
synthes
transfect
cell
unless
indic
otherwis
shrna
intracellularli
express
transfect
plasmid
control
pol
iii
promot
fold
inhibit
viru
product
repres
result
obtain
effici
sirna
shrna
stabl
express
shrna
obtain
use
lentivir
vector
b
snrna
stand
antisens
small
nuclear
rna
disrupt
cypa
splice
one
multipl
sirna
berkhout
assum
essenti
viral
sequenc
target
delet
option
therefor
one
like
two
nt
substitut
requir
per
target
sequenc
obtain
fair
level
resist
da
et
al
assum
mutat
need
obtain
complet
resist
assum
error
rate
revers
transcriptas
polymeras
chanc
viral
escap
singl
replic
cycl
studi
field
drugresist
indic
untreat
hivinfect
individu
contain
effect
viral
popul
size
rouzin
coffin
mean
substitut
alreadi
present
within
viral
popul
start
untreat
patient
moder
viral
load
mean
resist
like
occur
thu
may
inde
import
consid
sirna
combin
therapi
sirct
berkhout
four
effect
sirna
chanc
viral
escap
drop
practic
sirna
chemic
synthes
transfect
cell
unless
indic
otherwis
shrna
intracellularli
express
transfect
plasmid
control
pol
iii
promot
fold
inhibit
viru
product
repres
result
obtain
effici
sirna
shrna
nonessenti
viral
gene
viru
product
neg
affect
apoptosi
host
cell
b
hla
host
factor
requir
hbv
replic
c
nonessenti
viral
gene
nonessenti
viral
gene
play
role
cell
transform
mean
viral
escap
imposs
long
viral
suppress
complet
even
sever
assumpt
wrong
prospect
favour
one
achiev
effect
longterm
viral
suppress
altern
strategi
target
unmut
hostencod
function
import
viral
replic
essenti
surviv
host
cell
tabl
haasnoot
et
al
effect
rnaibas
antivir
therapi
still
face
seriou
technic
hurdl
major
one
deliveri
sirna
right
cell
recent
progress
achiev
field
simpl
conjug
sirna
cholesterol
chemic
link
termin
hydrozyl
group
sens
rna
strand
recent
report
trigger
tissu
deliveri
soutschek
et
al
intraven
inject
conjug
mice
result
uptak
sever
tissu
includ
liver
jejunum
heart
kidney
lung
fat
tissu
howev
mani
question
remain
method
see
applic
human
instanc
treatment
might
requir
lifetim
use
cholesterollow
compound
thu
research
improv
deliveri
system
base
protein
liposom
molecul
continu
apac
altern
rnaitrigg
gene
could
transfer
appropri
target
cell
gene
therapi
protocol
seem
ideal
suit
treatment
individu
chronic
infect
fail
standard
antiretrovir
therapi
chronic
infect
individu
infect
signific
fraction
matur
cell
day
lead
cell
kill
either
directli
indirectli
hivinduc
immun
system
thu
preferenti
surviv
even
minor
sirnaexpress
cell
result
outgrowth
time
one
could
treat
either
matur
immun
cell
blood
haematopoiet
stem
cell
patient
bone
marrow
put
back
patient
latter
cell
prolifer
matur
cell
move
peripheri
thu
form
constant
suppli
cell
resist
infect
mean
even
rel
ineffici
ex
vivo
gene
therapi
protocol
could
benefici
retrovir
especi
lentivir
vector
frequent
use
deliv
sirnaexpress
cassett
mammalian
cell
although
concern
former
vector
trigger
leukaemia
two
children
gene
therapi
trial
check
result
expect
soon
first
human
trial
use
lentivir
vector
lu
et
al
lu
et
al
rnaimedi
viru
inhibit
studi
larg
group
rna
virus
see
tabl
recent
studi
mice
suggest
rnai
hold
great
promis
prevent
treatment
infect
respiratori
virus
rna
genom
influenza
viru
human
parainfluenza
viru
hpiv
hrsv
bitko
et
al
ge
et
al
tompkin
et
al
zhang
et
al
due
limit
antiinfluenza
vaccin
drug
real
need
novel
strategi
inhibit
influenza
viru
worldwid
estim
half
million
death
per
year
attribut
influenza
viru
continu
threat
emerg
novel
pandem
strain
use
sirna
vivo
therapeut
must
deliv
effici
appropri
tissu
case
lung
lung
perhap
readili
transfect
organ
like
vascular
tissu
bodi
furthermor
inject
materi
first
travers
capillari
bed
lung
upon
intraven
administr
research
use
polyethyleneimin
pei
inject
intraven
intratrach
deliv
sirna
lentivir
dna
vector
express
shrna
ge
et
al
pei
cation
polym
use
deliv
dna
lung
cell
other
deliv
antiinfluenza
sirna
intranas
cation
transfect
reagent
oligofectamin
tompkin
et
al
reduct
viru
titr
lung
lethal
observ
antivir
administ
either
prior
subsequ
viru
challeng
similarli
replic
hrsv
hpiv
mice
could
block
intranas
deliveri
synthet
sirna
bitko
et
al
author
show
approach
effect
without
use
transfect
reagent
besid
synthet
sirna
also
intranas
administr
plasmid
express
shrna
hrsv
result
signific
decreas
viral
titr
zhang
et
al
find
suggest
low
dosag
inhal
intraven
administ
sirnasshrna
might
provid
easi
effici
basi
prophylaxi
antivir
therapi
respiratori
virus
human
popul
hcv
major
caus
chronic
hepat
hepatocellular
carcinoma
current
vaccin
avail
hcv
sever
group
use
rnai
target
hcv
replic
hcv
belong
famili
flavivirida
genom
encod
rna
posit
polar
cell
cultur
system
hcv
replic
studi
use
replicon
system
cell
model
hcv
replic
replicon
support
hcv
rna
transcript
protein
synthesi
produc
infecti
viru
region
target
includ
conserv
sequenc
capsid
utr
see
tabl
utr
hcv
rna
good
potenti
target
conserv
part
hcv
genom
harbour
intern
ribosom
entri
site
ire
requir
translat
research
use
sirna
shrna
block
hcv
replic
takigawa
et
al
addit
look
viru
replic
cell
transduc
lentivir
vector
stabli
express
hcv
specif
shrna
obtain
good
inhibit
hcv
shrna
target
shrna
transduc
cell
poor
inhibit
found
shrna
utr
howev
group
shown
utr
inde
good
target
kronk
et
al
seo
et
al
wilson
et
al
yokota
et
al
show
effect
sirna
shrna
still
difficult
predict
sinc
becam
clear
outbreak
sar
begin
caus
viru
current
known
sarscoronaviru
sarscov
research
tri
find
cure
new
viru
shown
shrna
sirna
could
effici
block
sarscov
replic
tissu
cultur
system
lu
et
al
wang
et
al
zhang
et
al
studi
main
target
polymeras
gene
wherea
one
paper
describ
inhibit
sarscov
target
spike
protein
essenti
particl
format
entri
zhang
et
al
addit
replic
newli
discov
human
coronaviru
van
der
hoek
et
al
could
also
inhibit
sirna
target
spike
gene
pyrc
et
al
prepar
sar
diseas
upper
airway
lung
could
rel
easi
administ
therapeut
sirna
influenza
viru
hrsv
hpiv
shown
viru
replic
lung
mice
inhibit
intraven
intranas
administr
sirnasshrna
bitko
et
al
ge
et
al
tompkin
et
al
zhang
et
al
follow
similar
rout
sirna
sarscov
might
effect
new
antivir
therapeut
contrast
rna
virus
rnai
dna
virus
target
viral
mrna
transcript
viral
genom
suggest
rnai
dna
virus
might
less
effect
rnai
rna
virus
howev
publish
data
rnai
mediat
inhibit
dna
virus
indic
case
hbv
member
hepadnavirida
genom
doublestrand
circular
dna
hbv
infect
caus
liver
cirrhosi
may
ultim
lead
hepatocellular
carcinoma
although
vaccin
develop
prevent
infect
hbv
remain
seriou
health
problem
mani
countri
number
studi
show
rnai
induc
synthet
sirna
block
hbv
cell
cultur
mous
model
system
hamasaki
et
al
klein
et
al
konishi
et
al
ying
et
al
instanc
giladi
et
al
show
inhibit
hbv
replic
mice
treat
synthet
sirna
target
small
hbv
surfac
antigen
hbsag
giladi
et
al
earlier
inhibit
hbv
liver
mice
obtain
intraven
inject
plasmid
express
shrna
core
hbsagpol
x
gene
mccaffrey
et
al
possibl
similar
approach
could
use
infect
patient
lower
viru
titr
besid
target
viral
rna
also
possibl
inhibit
hbv
replic
target
mrna
cellular
factor
requir
viru
replic
ni
et
al
shown
target
hla
protein
result
decreas
viru
replic
addit
shown
rnai
use
prevent
hcvor
hbvinduc
diseas
liver
silenc
express
cellular
fa
gene
hcv
hbv
infect
fasmedi
apoptosi
hepatocyt
trigger
selfdestruct
inflammatori
respons
liver
silenc
fa
express
synthet
sirna
block
repons
larg
dna
viru
infect
epitheli
neuron
cell
bhuyan
cowork
use
sirna
glycoprotein
e
ge
inhibit
replic
ge
import
celltocel
spread
evas
complement
antibodi
respons
silenc
express
ge
result
fourfold
inhibit
replic
bhuyan
et
al
inhibit
gamma
herpesviru
ebv
obtain
shrna
essenti
viral
gene
zta
chang
et
al
zta
involv
reactiv
ebv
import
express
lytic
gene
viral
dna
replic
addit
target
ebv
replic
one
report
describ
inhibit
ebv
oncogen
inhibit
pathogen
effect
ebv
infect
ebv
associ
develop
highli
metastat
nasopharyng
carcinoma
npc
import
develop
npc
viral
latent
membran
involv
cell
transform
tumour
metastasi
suppress
express
rnai
result
alter
cell
motil
surfac
adhes
transmembran
invas
abil
suggest
rnai
use
inhibit
metastat
potenti
ebvposit
carcinoma
cell
two
studi
use
rnai
inhibit
small
dna
viru
human
polyomaviru
jcv
orba
et
al
radhakrishnan
et
al
jcv
caus
progress
multifoc
leukoencephalopathi
pml
patient
impair
immun
system
pml
becom
major
neurolog
problem
among
patient
aid
studi
synthet
sirna
use
target
agno
tag
gene
result
inhibit
viru
replic
vitro
import
question
mark
concern
rnaitherapi
specif
introduc
sirna
may
neg
affect
product
activ
endogen
rnai
pathway
involv
regul
cellular
gene
express
particularli
import
grow
evid
biolog
signific
rnai
develop
bernstein
et
al
wienhold
et
al
also
need
prove
rnai
crosssil
cellular
mrna
sequenc
motif
resembl
actual
viral
target
genomewid
express
profil
yield
promis
result
chi
et
al
li
et
al
semizarov
et
al
studi
report
sirnatreat
caus
chang
express
dozen
cellular
gene
directli
target
jackson
et
al
persengiev
et
al
scacheri
et
al
howev
microarray
express
profil
may
provid
sensit
readout
compar
typic
function
screen
shrna
molecul
seem
critic
use
hairpin
stem
basepair
less
order
avoid
induct
interferon
respons
cytotox
effect
fish
kruithof
sirna
imperfect
complementar
silenc
gene
repress
mrna
translat
affect
level
mrna
three
four
mismatch
toler
system
saxena
et
al
find
combin
observ
gu
wobbl
recogn
regular
basepair
emphas
possibl
offtarget
silenc
sirna
studi
perform
synthet
sirna
concentr
ad
cell
may
also
critic
factor
persengiev
et
al
intracellularli
express
shrna
may
affect
cellular
gene
mean
bridg
et
al
therefor
obviou
use
rnaibas
therapeut
agent
requir
demonstr
absenc
advers
effect
cell
physiolog
anoth
issu
whether
sirna
induc
interferon
system
caus
cell
shut
respons
invad
rna
virus
contrast
plant
c
elegan
transfect
dsrna
longer
basepair
mammalian
cell
induc
interferon
pathway
via
dsrnadepend
protein
kinas
pkr
induc
antivir
respons
involv
nonspecif
degrad
rna
gener
inhibit
translat
sirna
suppos
detect
radar
interferon
system
may
complet
true
two
recent
paper
examin
effect
sirna
interferon
system
bridg
et
al
sledz
et
al
studi
report
nonspecif
chang
express
interferonstimul
gene
moss
taylor
one
studi
report
activ
pkr
synthet
sirna
sledz
et
al
find
consist
previou
result
manch
et
al
detail
character
minim
rna
motif
pkr
activ
reveal
follow
characterist
hairpin
possibl
imperfect
stem
flank
singlestrand
tail
zheng
bevilacqua
result
indic
sirna
pkractiv
rule
role
pkr
rnai
biolog
report
certain
gene
interferon
system
activ
upon
sirnaintroduct
cell
thu
provid
anoth
seriou
warn
offtarget
effect
may
common
initi
anticip
sledz
et
al
furthermor
dsrna
activ
sever
protein
kinas
cjun
ntermin
kinas
jnk
kappa
b
kinas
ikk
addit
pkr
induct
signal
pathway
alter
gene
express
regul
activ
transcript
factor
nuclear
factor
nf
interferon
regulatori
factor
irf
william
therefor
caution
must
exert
interpret
data
experi
use
rnai
technolog
suppress
specif
gene
import
first
add
basic
understand
sirna
exactli
work
rush
clinic
trial
among
thing
experi
need
repeat
anim
exactli
done
recent
heidel
et
al
regardless
inject
method
mice
sirna
fail
trigger
strong
type
interferon
respons
unlik
long
doublestrand
control
rna
poli
c
sirna
shown
silenc
gene
sequencespecif
manner
demonstr
reach
intracellular
target
absenc
interferon
inflammatori
respons
vivo
good
news
use
sirna
therapeut
altern
virus
could
exploit
rna
silenc
control
express
gene
viral
host
origin
first
exampl
recent
provid
ebv
larg
dna
viru
herp
famili
preferenti
infect
human
b
cell
pfeffer
et
al
small
rna
latent
ebvinfect
burkitt
lymphoma
cell
line
clone
origin
two
region
ebv
genom
comput
method
use
identifi
potenti
target
ebvencod
mirna
among
predict
target
regul
cell
prolifer
apoptosi
transcript
regul
compon
signal
transduct
pathway
although
target
verifi
experiment
strike
sever
gene
one
bind
site
particular
ebvmirna
degrad
cellular
dna
polymeras
demonstr
experiment
pfeffer
et
al
furthermor
express
ebvmirna
shown
differ
lytic
versu
latent
stage
suggest
tight
regul
viral
infect
viral
mirna
could
involv
tumour
format
may
explain
ebv
hide
well
member
herpesviru
famili
virus
larg
dna
genom
could
encod
mirna
order
exploit
rna
silenc
regul
host
viral
gene
express
theoret
experiment
studi
recent
identifi
sever
potenti
mirna
encod
rna
genom
bennass
et
al
omoto
et
al
addit
bennass
et
al
identifi
sever
correspond
cellular
rna
could
potenti
target
viral
mirna
viroid
singl
rna
molecul
protect
protein
coat
encod
protein
viroid
caus
sever
diseas
plant
sever
hypothes
propos
explain
diseas
induct
absenc
viral
protein
viroid
could
interrupt
function
unknown
host
cell
factor
use
small
regulatori
rna
influenc
host
gene
express
appear
viroid
pathogen
may
involv
rna
silenc
pathway
wang
et
al
report
engin
tomato
plant
express
virionderiv
noninfecti
hairpin
rna
symptom
mimick
viroid
infect
much
remain
learn
instanc
nuclearrepl
viroid
exploit
rnai
machineri
locat
cytoplasm
cellular
mrna
target
nevertheless
ebv
viroid
exampl
underscor
put
pathogen
function
virusderiv
small
rna
molecul
assum
rnai
act
antivir
mechan
human
one
would
predict
human
virus
develop
countermeasur
although
question
whether
rnai
play
major
role
antivir
defenc
vertebr
saksela
howev
unlik
plant
invertebr
vertebr
also
interferon
system
respond
dsrna
induc
synthesi
larg
group
protein
gener
inhibitori
effect
viru
multipl
bestcharacter
interferoninduc
gene
encod
pkr
kinas
oligo
synthetas
enzym
activ
respons
dsrna
goodbourn
et
al
activ
pkr
caus
inhibit
protein
synthesi
phosphoryl
oligoa
synthetas
induc
gener
rna
degrad
via
activ
rnase
l
lead
ultim
cell
death
via
apoptosi
thu
mammal
adapt
immun
system
alreadi
defenc
mechan
respond
dsrna
howev
discoveri
rnai
trigger
sirna
caplen
et
al
elbashir
et
al
short
effici
activ
interferon
respons
pathway
moss
taylor
suggest
rnai
may
also
play
role
cellular
defenc
infect
human
virus
thu
human
cell
may
two
altern
pathway
combat
dsrna
long
dsrna
activ
interferon
respons
pathway
wherea
short
dsrna
bp
activ
rnai
well
establish
mammalian
virus
evolv
defenc
strategi
suppress
neg
effect
interferon
respons
pathway
viru
multipl
vital
import
capac
viru
multipli
success
numer
virus
encod
protein
decoy
rna
inhibit
activ
pkr
surprisingli
larg
rang
differ
strategi
gale
katz
exampl
human
adenoviru
type
encod
two
approxim
nontransl
rna
polymeras
iii
transcript
highli
structur
va
rnai
va
rnaii
mathew
va
rnai
shown
stimul
protein
synthesi
infect
cell
transient
transfect
assay
block
activ
interferoninduc
antivir
defenc
system
kitajewski
et
al
svensson
akusjarvi
va
rnai
bind
pkr
act
competit
inhibitor
gale
katz
thu
prevent
viral
dsrna
produc
symmetr
transcript
viral
dna
activ
pkr
recent
demonstr
human
adenoviru
also
inhibit
rnai
machineri
late
time
infect
andersson
et
al
suppress
rnai
result
virusinduc
block
two
key
enzymat
activ
rnai
dicer
risc
show
va
rnai
va
rnaii
capac
suppress
rnai
transient
transfect
experi
mechanist
va
rna
appear
block
rnai
act
competit
substrat
squelch
dicer
sinc
va
rna
express
copiou
amount
late
time
infect
copiescel
soderlund
et
al
one
would
expect
produc
great
excess
aberrantli
form
dsrna
therefor
simpl
competit
inhibit
bind
dicer
would
suffici
explain
inhibitori
effect
va
rna
rnai
va
rna
might
function
suppressor
rnai
form
highli
structur
motif
imperfect
stem
resembl
precursor
mirna
therefor
might
sequest
dicer
act
compet
substrat
pseudosubstr
find
va
rnai
va
rnaii
inde
process
dicer
sirna
vitro
lytic
infect
support
model
show
va
rna
interact
dicer
unlik
dicer
inhibit
va
rna
requir
observ
inhibit
risc
infect
like
inhibit
risc
requir
anoth
yettobeidentifi
viral
factor
recent
lu
et
al
publish
similar
result
adenoviru
va
rnai
lu
cullen
collect
result
suggest
adenoviru
va
rna
antagon
cellular
defenc
pathway
direct
long
interferoninduc
short
rnaiinduc
dsrna
inactiv
two
key
enzym
pkr
dicer
find
impact
strategi
use
viral
vector
rna
silenc
purpos
possibl
exist
viral
suppressor
rnai
consequ
adenovir
vector
potenti
viral
vector
design
creat
optim
vector
sirna
deliveri
target
cell
instanc
va
rna
express
replic
adenovir
vector
also
nonrepl
adenovir
vector
thu
one
would
expect
va
rna
might
neg
affect
effici
adenovirusdeliv
shrna
possibl
adenovir
vector
may
alter
cellular
gene
express
result
competit
va
rna
cellular
mirna
seen
virusinfect
plant
kasschau
et
al
one
import
consequ
rna
silenc
revolut
abil
use
rnai
pathway
determin
gene
function
appli
rna
silenc
tool
agricultur
medicin
eg
protect
viral
infect
inde
rnai
therapi
expect
make
way
toward
clinic
trial
near
futur
interplay
rnai
virus
complex
virus
induc
suppressor
actual
target
rnai
silenc
mechan
interest
strong
argument
rna
primordi
biopolym
life
multifunction
enzym
replicon
rel
small
cadr
scientist
alway
dedic
studi
rna
rnai
brought
real
rna
revolut
seem
convert
scientist
